Islet Holdings Inc

Islet Holdings Inc. is a pioneering biotechnology company based in Salt Lake City, Utah, dedicated to revolutionizing diabetes treatment through innovative transplantation technologies. We specialize in the research, development, and commercialization of patented methods for isolating, culturing, cryopreserving, and protecting islet cells – the key to insulin production – using microencapsulation. Our core focus is on creating a safe and effective solution for individuals with insulin-dependent diabetes, offering a potential alternative to traditional insulin therapies.

Furthermore, Islet Holdings is actively engaged in the development of intellectual property related to hemp farming and CBD extraction, demonstrating a commitment to exploring diverse therapeutic applications of plant-derived compounds. With a history dating back to 1981, we are committed to advancing the field of regenerative medicine and improving the lives of patients worldwide.